ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

Griesmer To Leave NTP, Will Return To Oak Ridge

March 28, 1980

NCI Outlines Plan for Marin County Breast Cancer Review

November 22, 2002

Final Issue of ‘87

December 11, 1987

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994